CORINDUS VASCULAR ROBOTICS, INC
CVRS
CVRS was delisted on the 28th of October, 2019.
53 hedge funds and large institutions have $45.6M invested in CORINDUS VASCULAR ROBOTICS, INC in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 30 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less funds holding
Funds holding: 70 → 53 (-17)
47% less capital invested
Capital invested by funds: $85.4M → $45.6M (-$39.8M)
57% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.48M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$772K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$725K |
| 4 |
ECM
Element Capital Management
New York
|
+$508K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$478K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$6.27M |
| 2 |
BlackRock
New York
|
-$3.77M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.6M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1M |
| 5 |
FHAM
Folger Hill Asset Management
New York
|
-$891K |
CVRS Hedge Fund Activity: Q2 2018 in Review
53 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q2 2018, worth a combined $45.6M — down 47% from $85.4M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CVRS and 13 opened new positions — a net loss of 17 holders — while 11 trimmed existing stakes and 13 added.
The largest buyer was Millennium Management, adding an estimated $1.48M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $6.27M sold.
- 53 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q2 2018, down from 70 in Q1 2018.
- Funds reported $45.6M of CORINDUS VASCULAR ROBOTICS, INC stock for Q2 2018, down 47% quarter-over-quarter.
- 13 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q2 2018 and 30 closed out, a net change of -17 holders.
- The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q2 2018 was Millennium Management, an estimated $1.48M added.
- The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q2 2018 was Consonance Capital Management, an estimated $6.27M sold.
Based on aggregated 13F filings for Q2 2018.